From GlobeNewswire: 2024-06-20 02:00:00

The Global Skin Rash Treatment Market is projected to grow from USD 3.50 billion in 2023 to USD 6.45 billion by 2033, with a CAGR of 6.30%. Skin rashes can be caused by infections, allergies, autoimmune diseases, and more, leading to an increased demand for products and services in the skin rash treatment market. The psoriasis segment is expected to dominate the market, with corticosteroids showing the fastest growth. North America leads the market due to high healthcare spending and R&D efforts, while Asia Pacific is expected to grow rapidly. Major players in the market include Amgen, Sun Pharmaceutical Industries, and Johnson & Johnson. Recent developments include GenieBiome expanding its probiotics range in Singapore and Arcutis launching ZORYVE for seborrheic dermatitis in the US. The market is segmented by skin rash type, treatment type, and distribution channels, with North America, Europe, and Asia Pacific leading in regional analysis.



Read more at GlobeNewswire: Global Skin Rash Treatment Market Size To Worth USD 6.45